The Emergency Contraceptive Pills (ECPs) market has gained significant growth in recent years due to the increasing demand for these pills as a backup option for contraception. ECPs are a type of birth control method that is used after unprotected sexual intercourse, contraceptive failure, or sexual assault to prevent pregnancy. These pills contain hormones that work by delaying ovulation or preventing fertilization. ECPs are available as prescription and over-the-counter (OTC) drugs.
Market Size:
Apropos this report, global sales of emergency contraceptive pills are likely to witness dwindling growth over the span of next five years. During the forecast period, 2017-2022, the global market for emergency contraceptive pills is expected to incur a listless growth, reaching a value of over US$ 1,230 Mn.
Strategizing The Moves For The Next Decade? See Through Sample Of Emergency Contraceptive Pills Market Report! https://www.persistencemarketresearch.com/samples/18343
Market Segmentation:
The global Emergency Contraceptive Pills market is segmented based on product type, distribution channel, and region.
Based on product type, the market is segmented into levonorgestrel-based ECPs and ulipristal acetate-based ECPs. Levonorgestrel-based ECPs accounted for the largest share of the market in 2020 due to their effectiveness and easy availability.
Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies held the largest share of the market in 2020 due to their easy availability and accessibility.
Regional Analysis:
The global Emergency Contraceptive Pills market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the largest share of the market in 2020 due to the increasing awareness regarding family planning, the presence of major market players, and the availability of advanced healthcare infrastructure. Asia Pacific is expected to grow at the highest CAGR during the forecast period due to the increasing demand for ECPs, rising awareness regarding sexual health, and growing female population.
Key Players:
The global Emergency Contraceptive Pills market is highly competitive, with the presence of several market players. Some of the key players in the market are Teva Pharmaceutical Industries Ltd., Mylan N.V., HRA Pharma, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bayer AG, Piramal Enterprises Ltd., and Merck & Co., Inc.
Conclusion:
In conclusion, the global Emergency Contraceptive Pills market is expected to grow at a steady rate during the forecast period due to the increasing awareness regarding family planning and the rising number of unplanned pregnancies. Levonorgestrel-based ECPs and retail pharmacies are the major segments of the market. North America held the largest share of the market in 2020, while Asia Pacific is expected to grow at the highest CAGR during the forecast period. The market is highly competitive, with the presence of several market players.